chr5-140821900-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000529859.2(PCDHA5):āc.125C>Gā(p.Thr42Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T42N) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000529859.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDHA5 | NM_018908.3 | c.125C>G | p.Thr42Ser | missense_variant | 1/4 | ENST00000529859.2 | NP_061731.1 | |
PCDHA1 | NM_018900.4 | c.2394+33216C>G | intron_variant | ENST00000504120.4 | NP_061723.1 | |||
PCDHA2 | NM_018905.3 | c.2388+24548C>G | intron_variant | ENST00000526136.2 | NP_061728.1 | |||
PCDHA3 | NM_018906.3 | c.2394+18309C>G | intron_variant | ENST00000522353.3 | NP_061729.1 | |||
PCDHA4 | NM_018907.4 | c.2385+12328C>G | intron_variant | ENST00000530339.2 | NP_061730.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDHA5 | ENST00000529859.2 | c.125C>G | p.Thr42Ser | missense_variant | 1/4 | 1 | NM_018908.3 | ENSP00000436557 | P1 | |
PCDHA1 | ENST00000504120.4 | c.2394+33216C>G | intron_variant | 1 | NM_018900.4 | ENSP00000420840 | P1 | |||
PCDHA3 | ENST00000522353.3 | c.2394+18309C>G | intron_variant | 1 | NM_018906.3 | ENSP00000429808 | P1 | |||
PCDHA2 | ENST00000526136.2 | c.2388+24548C>G | intron_variant | 1 | NM_018905.3 | ENSP00000431748 | P1 | |||
PCDHA4 | ENST00000530339.2 | c.2385+12328C>G | intron_variant | 1 | NM_018907.4 | ENSP00000435300 | P1 | |||
ENST00000655235.1 | n.657+5993G>C | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251410Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135910
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461856Hom.: 0 Cov.: 35 AF XY: 0.00000550 AC XY: 4AN XY: 727230
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 15, 2023 | The c.125C>G (p.T42S) alteration is located in exon 1 (coding exon 1) of the PCDHA5 gene. This alteration results from a C to G substitution at nucleotide position 125, causing the threonine (T) at amino acid position 42 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at